Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study). J of Skin 2023, 7 (6), s262. https://doi.org/10.25251/skin.7.supp.262.